// App-Quantinova.ai

: Immune checkpoint inhibitors in the peri-operative setting in renal cell carcinoma: A meta-analysis of the randomized clinical trials.

Researchers

Presenter

  • Jorge Esteban Villarrubia

Principal Investigators

  • Lucía Carril-Ajuria

  • Alberto Carretero-González

  • Carmen Romero Ferreiro

  • Pablo Álvarez

  • Maria Ruiz-Vico

  • Daniel Castellano

  • Guillermo de Velasco

Medical Centers

  • Medical Oncology Department. Hospital Universitario La Paz, Madrid, Spain

  • Ramon y Cajal University Hospital, Medical Oncology Department, Madrid, Spain

  • Scientific Support Unit (i+12), Instituto de Investigación Sanitaria Hospital Universitario 12 de Octubre (imas12), Madrid, Spain

  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA

  • CHU Brugmann Brussels, Medical Oncology Department, Brussels, Belgium

Locations

  • Belgium

  • Spain

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Renal cell carcinoma

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved